• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌的诊断与治疗

Diagnosis and treatment of differentiated thyroid carcinoma.

作者信息

Cox Amy E, LeBeau Shane O

机构信息

Division of Endocrinology and Metabolism, University of Pittsburgh Medical Center, 200 Lothrop Street, E 1140 BST, Pittsburgh, PA 15261, USA.

出版信息

Radiol Clin North Am. 2011 May;49(3):453-62, vi. doi: 10.1016/j.rcl.2011.02.006.

DOI:10.1016/j.rcl.2011.02.006
PMID:21569904
Abstract

Thyroid cancer is the most common endocrine malignancy. Historically, the diagnosis has been made via fine-needle aspiration cytology; however, molecular marker analysis, particularly in indeterminate specimens, is beginning to play a more prominent role. Once the diagnosis of thyroid cancer is established, patients should undergo preoperative ultrasound evaluation followed by appropriate surgical resection, radioiodine ablation, and thyrotropin suppression. After the initial treatment, patients must be monitored regularly for recurrent disease utilizing clinical examination, thyroglobulin measurement, and radiological imaging.

摘要

甲状腺癌是最常见的内分泌系统恶性肿瘤。从历史上看,诊断是通过细针穿刺细胞学检查做出的;然而,分子标志物分析,尤其是在不确定的标本中,正开始发挥更突出的作用。一旦确诊为甲状腺癌,患者应接受术前超声评估,随后进行适当的手术切除、放射性碘消融和促甲状腺激素抑制治疗。初始治疗后,必须利用临床检查、甲状腺球蛋白测量和影像学检查对患者进行定期监测,以发现复发性疾病。

相似文献

1
Diagnosis and treatment of differentiated thyroid carcinoma.分化型甲状腺癌的诊断与治疗
Radiol Clin North Am. 2011 May;49(3):453-62, vi. doi: 10.1016/j.rcl.2011.02.006.
2
[Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer].[根据甲状腺结节和分化型甲状腺癌当前治疗方案确定的体位]
Endocrinol Nutr. 2010 Oct;57(8):370-5. doi: 10.1016/j.endonu.2010.07.001. Epub 2010 Sep 17.
3
[Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].[分化型甲状腺癌的诊断、治疗及随访]
Wien Med Wochenschr. 2005 Oct;155(19-20):429-35. doi: 10.1007/s10354-005-0219-8.
4
Follow-up of differentiated thyroid carcinoma.分化型甲状腺癌的随访
Minerva Endocrinol. 2004 Dec;29(4):161-74.
5
Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.重组人促甲状腺素辅助 131I 消融术前甲状腺球蛋白测定在检测分化型甲状腺癌转移灶中的应用
Clin Endocrinol (Oxf). 2008 Oct;69(4):659-63. doi: 10.1111/j.1365-2265.2008.03244.x. Epub 2008 Mar 18.
6
Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.甲状腺乳头状癌的诊断、治疗、预后因素及长期结局
Minerva Endocrinol. 2008 Dec;33(4):359-79.
7
Treatment for microcarcinoma of the thyroid--clinical experience.甲状腺微小癌的治疗——临床经验
Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d.
8
[Differentiated thyroid cancer -- 2009].[分化型甲状腺癌——2009年]
Orv Hetil. 2011 Jan 30;152(5):163-70. doi: 10.1556/OH.2011.29028.
9
Circulating thyroid cancer markers.循环甲状腺癌标志物
Curr Opin Endocrinol Diabetes Obes. 2007 Oct;14(5):383-8. doi: 10.1097/MED.0b013e3282eeb2f4.
10
Contemporary management of papillary carcinoma of the thyroid gland.甲状腺乳头状癌的现代管理
Expert Rev Anticancer Ther. 2009 Mar;9(3):317-29. doi: 10.1586/14737140.9.3.317.

引用本文的文献

1
2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.2020年中国甲状腺结节超声恶性风险分层指南:C-TIRADS
Endocrine. 2020 Nov;70(2):256-279. doi: 10.1007/s12020-020-02441-y. Epub 2020 Aug 21.
2
Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.BRAF基因和促甲状腺激素受体与甲状腺微小乳头状癌颈部淋巴结转移的相关性
Oncol Lett. 2019 Jan;17(1):183-194. doi: 10.3892/ol.2018.9572. Epub 2018 Oct 12.